The Gastroenterology Market in 2026

The global gastroenterology market was worth roughly $41.19 billion in 2025, up from $38.85 billion in 2024, and is forecast to reach about $69.68 billion by 2034 at a 6.04% CAGR (Towards Healthcare, 2025). A second house puts the 2034 figure at $69.48 billion on a near-identical ~6% growth path (Precedence Research, 2025). Both numbers describe the same demand engine: an ageing population, rising rates of GI disease, expanded colorectal screening, and a shift toward less invasive, lower-cost outpatient procedures.

The United States is the single largest slice. US gastroenterology is projected to reach $23.4 billion by 2034 (Dimension Market Research, 2025), and the country spent an estimated $111.8 billion on GI healthcare in 2021. For a new practice, the relevant takeaway is not the headline trillion-dollar healthcare figure that generic plans quote. It is that demand for colonoscopy, upper endoscopy, and chronic GI disease management is structurally rising while the screening age band keeps widening.

Who buys, and what triggers the visit

GI demand is rarely discretionary, which is why a strong plan segments by referral pathway rather than by vague demographics. The three segments that matter for a new practice are screening patients (driven by primary-care referral and the lowered colorectal screening age), symptomatic patients (reflux, abdominal pain, rectal bleeding, IBS, IBD), and chronic-management patients who return on a schedule. Screening volume is the most forecastable; chronic management is the most defensible because it produces recurring visits and procedure follow-ups.

Your business plan should quantify the local referral base: how many primary-care physicians sit inside your catchment, what the average wait time is at incumbent practices, and which payers dominate the area. A practice that opens with two or three committed referring groups behaves very differently in Year 1 than one relying on cold patient search. Lenders read that referral detail as the difference between a hopeful forecast and a grounded one.

Each segment also carries different economics, and the plan should say so. Screening colonoscopy is volume-driven and reimbursement-sensitive, so it rewards scheduling efficiency and a healthy commercial payer share. Symptomatic care converts faster because the patient has an active problem, and it often opens the door to follow-up procedures. Chronic management, IBD, chronic liver disease, long-term reflux, is the quiet profit centre: it produces predictable recurring visits, surveillance endoscopy on a schedule, and the kind of continuity that an independent practice can deliver better than a sprawling group. A plan that shows what share of Year-3 revenue comes from recurring chronic-care relationships reads as far more durable than one built entirely on one-off screening volume.

Demographics reinforce all three. An ageing population, rising rates of GI disease tied to diet, and the lowered colorectal screening threshold mean the addressable pool inside almost any catchment is growing rather than shrinking. The risk in a GI plan is rarely insufficient demand; it is capacity, access, and the speed at which a new practice can get in-network and keep its rooms full.

The competitive picture is consolidating

US gastroenterology has consolidated faster than almost any other specialty. GI Alliance now spans roughly 800 locations and took a $785 million private-equity investment from Apollo Global Management in 2022. Gastro Health runs about 152 locations with 475 physicians; United Digestive operates 81 locations and was acquired by Kohlberg & Company for $500 million in 2023; Texas Digestive Disease Consultants fields 556 physicians; and One GI is backed by Webster Equity Partners (Becker's ASC, 2024). A new independent practice is not competing on scale against these groups; it competes on access, continuity of care, and physician relationships. Your plan should say so plainly and show where an independent wins: shorter waits, the same gastroenterologist at every visit, and tighter referral feedback loops.

Questions Founders Ask First

These are the questions gastroenterologists ask before they write a single line of a plan. Each one belongs in the document because every lender and partner will ask it too.

Do I have to build a surgery center to make this work?

No, and assuming you do is the most expensive early mistake. In-office endoscopy lets you start with a procedure room rather than a licensed facility, defers Certificate-of-Need and Medicare-facility steps, and still captures professional fees. An ambulatory surgery center adds facility-fee income but layers on state licensure, accreditation, and capital. Model the office-first path as your base case and the ASC as a Year-2 or Year-3 option.

How long until I actually get paid?

Payer credentialing commonly takes 60 to 120 days per plan, and you cannot bill a payer until you are in-network with it. A realistic GI forecast shows a collections ramp, not full revenue from Month 1. This single assumption changes the size of your working-capital reserve more than any other.

Is a solo GI practice still viable next to the supergroups?

Yes, where access and continuity matter. Independents win on shorter wait times and consistent physician relationships. The plan should name the local incumbents, their typical wait, and the referral relationships you can secure before opening.

What changed in reimbursement that I need to model?

The 2026 Medicare Physician Fee Schedule cuts ASC and hospital-outpatient endoscopy by roughly 8% versus 2025 while shifting dollars toward office-based endoscopy. If your model still uses 2025 rates for facility procedures, it overstates revenue. The next sections build the numbers around the 2026 reality.

What It Costs to Open a Gastroenterology Practice

A single-specialty gastroenterology practice with in-office endoscopy typically needs $200,000 to $500,000 (£160,000 to £400,000) to launch. Procedural specialties sit at the upper end of medical-practice startup ranges because of the endoscopy stack and reprocessing requirements; a primary-care office can open for far less (DoctorsManagement, 2026). The figure swings on whether you buy new or refurbished scopes, whether you lease or fit out a procedure suite, and how long your payroll reserve has to last while credentialing clears.

The single most common forecasting error here is treating the startup number as a one-time spend and stopping there. The capital that actually keeps a GI practice alive is the working-capital reserve that bridges the gap between opening the doors and collecting from payers. Because in-network credentialing runs 60 to 120 days per plan, a practice can be performing procedures for two or three months before meaningful cash arrives. Build the reserve around that reality, and the startup budget becomes a survival plan rather than a wish list. A useful discipline is to split the budget into three buckets, capital equipment, fixed setup, and working capital, and to size the third bucket off the credentialing timeline rather than off a generic rule of thumb.

Cost Breakdown

• Endoscopy stack (colonoscope, processor, light source, monitor): $20K-$150K new; individual colonoscopes run $5K-$100K (£16K-£120K)
• Premises lease & clinical fit-out: lease $2K-$8K/mo; fit-out $40K-$120K (£35K-£100K)
• Reprocessing / automated endoscope reprocessor & sterilisation: $15K-$45K (£12K-£36K)
• EHR & practice-management software: $5K-$25K (£4K-£20K)
• Staffing reserve (3-6 months payroll): $60K-$200K/yr for a solo practice with 2-3 staff (£48K-£160K)
• Licensing, CON, accreditation & legal: $5K-$15K+ (£5K-£12K)
• Marketing & patient acquisition: $6K-$40K (£5K-£32K)

Funding Routes

In the US, SBA 7(a) loans (up to $5M) are the workhorse for medical-practice startups, alongside dedicated equipment financing for the endoscopy stack and conventional practice loans. In the UK, Start Up Loans (up to £25,000 at 6% fixed) cover early costs, with commercial healthcare lenders and asset finance handling the larger equipment line. Most founders blend personal capital, an SBA or practice loan, and equipment leasing so the scopes are financed against the income they generate rather than paid for upfront.

SBA & Practice Lending for GI Founders

Healthcare borrowers are among the strongest applicants the SBA sees. Healthcare and social-assistance firms post approval rates in the 60-65% range at traditional banks, well above the all-industry average, and healthcare makes up roughly 8-10% of total SBA 7(a) loan volume each year (Crestmont Capital, 2025). For loans of $150,000 or less the SBA guarantees up to 85%, and up to 75% above that threshold, which is why a lender will work with a credible GI plan even when the equipment ask is large (U.S. Small Business Administration, 2025).

What the bank reads first in a GI submission: projected procedure volume tied to a named referral base, payer mix with a realistic in-network timeline, the equipment list with quotes, and a debt-service coverage ratio that survives the credentialing ramp. A plan that shows collections starting in Month 3 or 4 rather than Month 1, and still services debt, is far more bankable than one that assumes instant full revenue.

It also helps to understand why healthcare clears underwriting more easily than most sectors. Lenders see GI as durable, referral-driven demand with strong physician earning power behind the loan, which is why the specialty borrows comfortably even when the equipment ask is large. The flip side is that underwriters know the specialty, so a thin or recycled plan stands out immediately. The submissions that win are the ones that read like the founder has actually modelled their own numbers: a procedure-volume build tied to named referrers, a collection-per-case figure weighted by the local payer mix rather than a national average, and a working-capital line sized to the credentialing calendar. Those three details signal that the borrower understands the business they are about to run, and that is ultimately what a lender is underwriting.

• SBA 7(a): up to $5M; best fit for the blended premises + equipment + working-capital ask
• Equipment financing / leasing: secures the endoscopy stack against its own cash flow, preserving the 7(a) for soft costs
• UK Start Up Loans: up to £25,000 at 6% fixed, useful for first-year soft costs before larger asset finance
• Practice acquisition loans: relevant if you buy into or out of an existing group rather than building from scratch

Endoscopy Equipment Budget

Equipment is the line that separates a GI practice plan from a generic medical-office plan, and it is where lenders expect to see real quotes rather than round numbers. New endoscopy systems typically run $20,000 to $150,000 depending on imaging capability and brand, while individual scopes vary widely: rigid endoscopes $1,000-$20,000, flexible endoscopes $3,000-$50,000, and colonoscopes $5,000-$100,000 (MD Endoscopy, 2025). Many founders cut the opening capital sharply by buying certified refurbished Olympus or Pentax units for the second scope in the rotation rather than two new ones.

The decision that drives this budget is scope inventory depth. A single colonoscope cannot keep pace with a busy procedure day because each unit must be cleaned and run through an automated endoscope reprocessor between cases. Two to three colonoscopes plus a gastroscope is the practical minimum for a two-physician room, and that inventory choice flows straight into your daily procedure-throughput assumption.

• Video processor & light source (e.g. Olympus EVIS, Pentax): $15K-$60K, the hub the scopes connect to
• Colonoscopes (2-3 in rotation): $5K-$100K each, new or certified refurbished
• Gastroscope for upper endoscopy: $3K-$50K
• Automated endoscope reprocessor (AER) & drying/storage cabinet: $15K-$45K
• Procedure monitors & documentation/imaging system: $5K-$20K
• Patient monitoring & sedation equipment (capnography, pulse oximetry): $8K-$25K
• Procedure stretchers, recovery bays & crash cart: $10K-$30K
• Consumables (biopsy forceps, snares, hemostatic clips, CO2 insufflation): recurring $2K-$6K/month

Most of this is financeable. Equipment leasing against the income the scopes produce keeps the SBA 7(a) free for premises and working capital, and it spreads the cost across the years the asset earns rather than draining the launch reserve on day one.

How a Gastroenterology Practice Earns

GI revenue comes from four buckets: office evaluation-and-management visits, diagnostic and therapeutic endoscopy (the financial core), pathology and ancillary services, and, for owner-operators, facility-fee income from an ASC. Office-based practices commonly run 15-30% net margins, and gastroenterologist compensation averaged $644,422 in 2025, a 5% jump over 2024 per AMGA's compensation survey (AMN Healthcare, 2025).

The 2026 reimbursement shift you must model

This is where generic templates fail. Under the 2026 Medicare Physician Fee Schedule, ASC and hospital-outpatient endoscopy faces an average 8% cut versus 2025. Colonoscopy with snare polypectomy (CPT 45385) pays roughly $18.00 less per case, and colonoscopy with biopsy about $14.65 less. In aggregate, CMS is moving about $58 million away from facility-based GI endoscopy and more than $37 million toward office-based endoscopy and E/M (American College of Gastroenterology, 2025). The practical consequence: a 2026 GI plan should weight office-based endoscopy more heavily than a plan written two years ago would have, and the site-of-service split becomes a real strategic lever rather than an afterthought.

A worked unit-economics example

Take a two-physician practice running 14 colonoscopies a day, four days a week, roughly 2,900 procedures a year. At a blended collection of about $520 per case across professional and (where owned) facility components, procedure revenue lands near $1.5M before E/M visits and ancillaries. Layer in office visits, follow-ups, and chronic-disease management and a mature two-physician practice can clear $2M+ in gross collections. The same model under 2025 facility rates would have shown more per case; building it on 2026 rates is what keeps the forecast honest in front of a lender.

The levers that move this number are procedure throughput (room turnover and scheduling discipline), payer mix (commercial versus Medicare blend), no-show rate on screening slots, and reprocessing turnaround that limits how many cases a single scope inventory can support per day.

In-office vs ASC vs hospital: the site-of-service decision

Where a procedure happens changes both who pays and how much the practice keeps, and a 2026 GI plan should treat this as a deliberate strategic choice rather than a default. Three models sit on the table:

• In-office endoscopy: lowest capital and regulatory load, the model CMS is now rewarding, and the cleanest path to opening. The practice captures the professional fee and, in the office setting, more of the procedure value stays in-house. Best base case for a new independent.
• Ambulatory surgery center (owned): adds a facility fee and profit distributions of $75,000 to $200,000-plus a year per owner, with return often inside three to five years, but it carries state licensure (43 states), frequently a Certificate of Need, Medicare certification, and accreditation. Best as a Year-2 or Year-3 expansion once volume is proven.
• Hospital outpatient department: least capital exposure but the lowest share of procedure economics retained by the physician, and the setting hit hardest by the 2026 reimbursement cut. Useful as a bridge, weak as a long-term base.

The honest version of this analysis is what makes a GI plan bankable. A model that opens office-first, proves procedure volume, then layers an ASC on top once the referral engine is running tends to read as far more credible than one that asks a lender to fund a licensed surgery center on day one against unproven demand.

Operations & Staffing

In a GI practice, margin is made or lost in the procedure room. Two practices with the same scope inventory and the same referral base can post very different bottom lines depending on room turnover, scheduling discipline, and how fast a scope returns to service after reprocessing. The operations section of your plan should describe the procedure day in concrete terms: how many rooms, how many scopes in rotation, the target minutes per colonoscopy slot, and the reprocessing cycle time that caps daily volume.

The core staffing model

A lean two-physician practice runs on a tight team, and the plan should show each role tied to a revenue or compliance function rather than as a generic headcount. The typical opening team:

• Gastroenterologists (1-2): the procedure and E/M revenue engine
• Nurse practitioner or physician assistant: extends office-visit capacity and pre/post-procedure workups
• Registered nurses (procedure & recovery): sedation monitoring and recovery, often 2+ for a single procedure room
• Endoscopy technician: scope handling and reprocessing, the role that protects your throughput
• Front-office & scheduling: referral intake, insurance verification, and prep instructions
• Billing / RCM (in-house or outsourced): the function that converts procedures into collected dollars

Staffing reserves of $60,000 to $200,000 a year cover a solo practice with two to three staff, and the plan should hold three to six months of that payroll in startup capital so the practice survives the credentialing ramp before collections catch up.

Year-one operating priorities

• Lock the reprocessing workflow and infection-control protocol before the first patient, this is both a compliance gate and a throughput driver.
• Define owner KPIs: procedures per room-day, no-show rate, days in accounts receivable, and collection per case by payer.
• Stand up billing and credentialing on day one so the in-network clock starts as early as possible.
• Build a referral feedback loop so every referring physician gets a timely report, the single biggest driver of repeat referrals.

The difference between an average GI operator and a strong one usually comes down to four things: room turnover, scope availability, scheduling that keeps screening slots full, and a billing process that does not let earned revenue age in receivables.

Referrals & Patient Growth

Most GI volume arrives by referral, not by advertising, so the growth plan should read more like a relationship strategy than a marketing budget. The practices that ramp fastest open with two or three primary-care groups already committed to send patients, then widen from there. A business plan that names those relationships, or a credible plan to build them, de-risks the whole revenue forecast.

• Primary-care referral development: direct outreach, fast report turnaround, and easy referral channels for local family-medicine and internal-medicine practices
• Screening demand capture: position the practice around the widened colorectal screening age band, where demand is most forecastable
• Online presence: a findable site, accurate provider directories, and reviews that matter to self-referring symptomatic patients
• Wait-time advantage: when incumbents have multi-week waits, faster access is the single most persuasive message to both referrers and patients

Tie each channel back to the forecast: expected referrals per source per month, the conversion to booked procedures, and the no-show rate that erodes a full schedule. A plan that connects referral relationships to procedure volume, rather than quoting a vague marketing spend, is the one a lender treats as grounded.

Licensing & Accreditation Requirements

Licensing for a gastroenterology practice depends on whether you run office-based endoscopy or a licensed surgery center, and it varies sharply by jurisdiction. Below are the specifics that belong in your plan. The pattern to understand is that office-based endoscopy clears a much shorter regulatory checklist than a licensed facility: you need your medical credentials, payer enrolment, and standard clinical compliance, but you avoid the facility-licensure, Certificate-of-Need, and accreditation layers that a surgery center triggers. That difference is one of the strongest arguments for opening office-first and adding a facility later, and your plan should make the regulatory contrast explicit so a lender sees you have scoped the compliance burden accurately.

United States

• State medical licence plus ABIM (or AOA) gastroenterology board certification
• DEA registration for controlled substances used in sedation
• Payer credentialing with Medicare and commercial plans (60-120 days each)
• OSHA bloodborne-pathogen compliance and HIPAA safeguards
• If operating an ASC: state ASC licensure (required in 43 states), often a Certificate of Need before licensure, Medicare certification under 42 CFR 416, and accreditation from AAAHC, the Joint Commission, or AAAASF (Becker's ASC, 2025)

United Kingdom

• Care Quality Commission (CQC) registration to operate a regulated clinical service
• JAG endoscopy accreditation via the Royal College of Physicians' Joint Advisory Group, assessable only after 9-12 months of operation, on a five-year cycle, and mandatory to deliver NHS bowel cancer screening (JAG / RCP, 2024)
• GMC registration with five-yearly revalidation
• Professional indemnity insurance (£10M+ typical for medical work)
• Clinical-waste disposal licence and GDPR / information-governance compliance

Canada

• Provincial College of Physicians and Surgeons licensure plus Royal College subspecialty certification
• Provincial out-of-hospital / independent health facility accreditation where endoscopy is performed (for example, the CPSO Out-of-Hospital Premises Inspection Program in Ontario)
• Provincial business registration and workers' compensation coverage (WSIB / WorkSafe)

Mistakes That Sink Gastroenterology Plans

After reviewing healthcare plans across dozens of specialties, the same avoidable errors show up in GI submissions. Each one is easy to fix before a lender or partner ever sees the document.

• Using 2025 reimbursement rates. The 2026 MPFS cuts facility endoscopy ~8%. A model on old rates overstates revenue and dies in due diligence.
• Assuming an ASC from day one. Treating a surgery center as mandatory inflates the capital ask and the regulatory burden. Validate office endoscopy first.
• Ignoring Certificate of Need and state variation. ASC licensure rules differ across 43 states; a plan that glosses over CON looks naive to a healthcare lender.
• Under-budgeting reprocessing and infection control. The automated endoscope reprocessor, scope inventory, and compliance are not optional line items.
• Forecasting from physician salary, not collections. Revenue is collections net of payer mix and the credentialing lag, not a headline salary figure.

Sample Business Plan Preview

Preview the structure and financial outputs a buyer receives. These visual mockups are generated from the same assumptions used throughout this page.

What's in the Template

Every Avvale business plan template includes these sections, pre-structured for a gastroenterology practice:

• Executive Summary, the practice at a glance, written to hold a lender's attention in 60 seconds
• Company Overview, legal structure, ownership, location, and the office-vs-ASC decision
• Industry Analysis, GI market size, screening demand, and the 2026 reimbursement shift
• Patient & Referral Analysis, referral base, payer mix, and the symptomatic / screening / chronic split
• Competitor Analysis, local incumbents, supergroup pressure, and where an independent wins
• Marketing Plan, referral development, patient acquisition, and online presence
• Operations Plan, procedure scheduling, reprocessing workflow, staffing, and compliance milestones
• Management Team, physician bios, credentials, advisory support, and key hires

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, procedure-volume drivers, and a startup capital table. You can also compare adjacent specialties using our cardiology practice business plan template or the broader private clinic business plan template, and browse the full library on our free business plan templates hub.

Frequently Asked Questions

Useful Links & Resources

These links were preserved from the live page so important references and partner links are not lost during the page refresh.

• Facebook
• Instagram
• LinkedIn
• YouTube